333 related articles for article (PubMed ID: 21448451)
1. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH) gel.
Bomback AS; Tumlin JA; Baranski J; Bourdeau JE; Besarab A; Appel AS; Radhakrishnan J; Appel GB
Drug Des Devel Ther; 2011 Mar; 5():147-53. PubMed ID: 21448451
[TBL] [Abstract][Full Text] [Related]
2. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
3. Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial.
Bomback AS; Canetta PA; Beck LH; Ayalon R; Radhakrishnan J; Appel GB
Am J Nephrol; 2012; 36(1):58-67. PubMed ID: 22722778
[TBL] [Abstract][Full Text] [Related]
4. Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.
Hogan J; Bomback AS; Mehta K; Canetta PA; Rao MK; Appel GB; Radhakrishnan J; Lafayette RA
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2072-81. PubMed ID: 24009220
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G
Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
7. Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH).
Bomback AS; Radhakrishnan J
Discov Med; 2011 Aug; 12(63):91-6. PubMed ID: 21878186
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathy.
Hladunewich MA; Cattran D; Beck LH; Odutayo A; Sethi S; Ayalon R; Leung N; Reich H; Fervenza FC
Nephrol Dial Transplant; 2014 Aug; 29(8):1570-7. PubMed ID: 24714414
[TBL] [Abstract][Full Text] [Related]
9. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
Liang Q; Li H; Xie X; Qu F; Li X; Chen J
Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
[TBL] [Abstract][Full Text] [Related]
12. Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24.
Rauen T; Michaelis A; Floege J; Mertens PR
Clin Nephrol; 2009 Jun; 71(6):637-42. PubMed ID: 19473632
[TBL] [Abstract][Full Text] [Related]
13. Advanced diabetic nephropathy with nephrotic range proteinuria: a pilot study of the long-term efficacy of subcutaneous ACTH gel on proteinuria, progression of CKD, and urinary levels of VEGF and MCP-1.
Tumlin JA; Galphin CM; Rovin BH
J Diabetes Res; 2013; 2013():489869. PubMed ID: 24159603
[TBL] [Abstract][Full Text] [Related]
14. Complete Remission in the Nephrotic Syndrome Study Network.
Gipson DS; Troost JP; Lafayette RA; Hladunewich MA; Trachtman H; Gadegbeku CA; Sedor JR; Holzman LB; Moxey-Mims MM; Perumal K; Kaskel FJ; Nelson PJ; Tuttle KR; Bagnasco SM; Hogan MC; Dell KM; Appel GB; Lieske JC; Ilori TO; Sethna CB; Fervenza FC; Hogan SL; Nachman PH; Rosenberg AZ; Greenbaum LA; Meyers KE; Hewitt SM; Choi MJ; Kopp JB; Zhdanova O; Hodgin JB; Johnstone DB; Adler SG; Avila-Casado C; Neu AM; Hingorani SR; Lemley KV; Nast CC; Brady TM; Barisoni-Thomas L; Fornoni A; Jennette JC; Cattran DC; Palmer MB; Gibson KL; Reich HN; Mokrzycki MH; Sambandam KK; Zilleruelo GE; Licht C; Sampson MG; Song P; Mariani LH; Kretzler M
Clin J Am Soc Nephrol; 2016 Jan; 11(1):81-9. PubMed ID: 26656320
[TBL] [Abstract][Full Text] [Related]
15. Role of Rituximab in Patients with Resistant Nephrotic Syndrome.
Singh S; Agarwal D; Gupta R; Malhotra V; Bhardwaj S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443437
[TBL] [Abstract][Full Text] [Related]
16. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R; Imai E; Maruyama S; Yokoyama H; Sugiyama H; Nitta K; Tsukamoto T; Uchida S; Takeda A; Sato T; Wada T; Hayashi H; Akai Y; Fukunaga M; Tsuruya K; Masutani K; Konta T; Shoji T; Hiramatsu T; Goto S; Tamai H; Nishio S; Shirasaki A; Nagai K; Yamagata K; Hasegawa H; Yasuda H; Ichida S; Naruse T; Nishino T; Sobajima H; Tanaka S; Akahori T; Ito T; Terada Y; Katafuchi R; Fujimoto S; Okada H; Ishimura E; Kazama JJ; Hiromura K; Mimura T; Suzuki S; Saka Y; Sofue T; Suzuki Y; Shibagaki Y; Kitagawa K; Morozumi K; Fujita Y; Mizutani M; Shigematsu T; Kashihara N; Sato H; Matsuo S; Narita I; Isaka Y
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy.
Berg AL; Nilsson-Ehle P; Arnadottir M
Kidney Int; 1999 Oct; 56(4):1534-43. PubMed ID: 10504505
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus.
Roberti I; Vyas S
Pediatr Nephrol; 2010 Jun; 25(6):1117-24. PubMed ID: 20217433
[TBL] [Abstract][Full Text] [Related]
19. ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal.
Chakraborty R; Mehta A; Nair N; Nemer L; Jain R; Joshi H; Raina R
Int J Nephrol; 2020; 2020():2597079. PubMed ID: 32566293
[TBL] [Abstract][Full Text] [Related]
20. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
